In this study, novel bio-inspired in situ hydrogels as tissue adhesives and hemostatic materials were designed and prepared based on ɛ-polylysine-grafted poly(ethylene glycol) and tyramine via enzymatic cross-linking. The enzymatic cross-linked method enabled fast gelation within seconds, which facilitated its therapeutic applications. By changing the cross-linking conditions, the storage modulus of the hydrogels could be tunable and the mechanical strength influenced the tissue adhesiveness of the hydrogels. Besides, the hydrogels showed fine network structures with appropriate pore sizes, which were thought to be a contributing factor to the strong adhesiveness. Benefiting from the strong mechanical properties and fine network structures, the ɛ-polylysine-grafted poly(ethylene glycol) and tyramine hydrogels exhibited superior wound-healing and hemostatic ability compared to conventional and commercially available medical materials. Moreover, indirect cytotoxicity assessment indicated that the ɛ-polylysine-grafted poly(ethylene glycol) and tyramine hydrogels were nontoxic to the L929 cell. These results demonstrated that the enzymatic cross-linked in situ ɛ-polylysine hydrogels hold high potential for tissue sealants and hemostatic materials.
IshiharaMNakanishiKOnoK. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials2002; 23: 833–840.
2.
OgdenSGriffithsTWJ. A review of minimally invasive cosmetic procedures. Dermatology2008; 159: 1036–1050.
3.
OtaniYTabataYIkadaY. Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide. Biomaterials1998; 19: 2091–2098.
4.
AnsethKSMettersATBryantSJ. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release2002; 78: 199–209.
5.
RazzakMTDarwisDZainuddinSR. Irradiation of polyvinyl alcohol and polyvinyl pyrrolidone blended hydrogel for wound dressing. Phys Chem2001; 62: 107–113.
6.
PeppasNAMongiaNK. Ultrapure poly(vinyl alcohol) hydrogels with mucoadhesive drug delivery characteristics. Eur J Pharm Biopharm1997; 43: 51–58.
7.
BrennanM. Fibrin glue. Blood Rev1991; 5: 240–244.
8.
WoodwardSCHerrmannJBCameronJL. Histotoxicity of cyanoacrylate tissue adhesive in the rat. F Ann Surg1965; 162: 113–122.
9.
HoffmanAS. Hydrogels for biomedical applications. Adv Drug Deliver Rev2002; 54: 3–12.
10.
KamathARParkK. Biodegradable hydrogels in drug delivery. Adv Drug Deliver Rev1993; 11: 59–84.
11.
WichterleOLimD. Hydrophilic gels in biologic use. Nature1960; 185: 117–123.
12.
KimSHWonCYChuCC. Synthesis and characterization of dextran-based hydrogel prepared by photocrosslinking. Carbohydr Polym1999; 40: 183–190.
13.
CatherineKKPeterXM. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials2001; 22: 511–521.
14.
BurkothAKAnsethKS. Review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials2000; 21: 2395–2404.
15.
Van TommeSRVan SteenbergenMJDe SmedtSC. Self-gelling hydrogels based on oppositely charged dextran microspheres. Biomaterials2005; 26: 2129–2135.
16.
RongJChristineHZhongZY. Enzyme-mediated fast in situ formation of hydrogels from dextran–tyramine conjugates. Biomaterials2007; 28: 2791–2800.
17.
SungHWHuangRNHuangLLH. Feasibility study of a natural crosslinking reagent for biological tissue fixation. J Biomed Mater Res1998; 42: 560–567.
18.
FerrettiMMarraKGKobayashiKJ. Controlled in vivo degradation of genipin crosslinked polyethylene glycol hydrogels within osteochondral defects. Tissue Eng2006; 12: 2657–2663.
19.
KurisawaMChungJEYangYY. Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun2005; 43: 12–14.
20.
ParkKMKoKSJoungYK. In situ cross-linkable gelatin–poly(ethylene glycol)–tyramine hydrogel via enzyme-mediated reaction for tissue regenerative medicine. J Mater Chem2011; 21: 13180–13187.
21.
ParkKMShinYMJoungYK. In situ forming hydrogels based on tyramine conjugated 4-arm-PPO–PEO via enzymatic oxidative reaction. Biomacromolecules2010; 11: 706–712.
22.
TranNQJoungYKLihE. In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules2011; 12: 2872–2880.
23.
ChenQLiangSThouasGA. Synthesis and characterisation of poly(glycerol sebacate)-co-lactic acid as surgical sealants. Soft Matter2011; 7: 6484–6492.
24.
ChenTHRabeeaJJMartinK. Gelatin-based biomimetic tissue adhesive. Potential for retinal reattachment. J Biomed Mater Res Part B Appl Biomater2006; 77B: 416–422.
OelkerAMGrinstaffMW. Ophthalmic adhesives: a materials chemistry perspective. J Mater Chem2008; 18: 2521–2536.
27.
RyouMThompsonCC. Tissue adhesives: a review. Tech Gastrointest Endosc2006; 8: 33–37.
28.
ZhangYFengXHXuH. ɛ-Poly-L-lysine production by immobilized cells of Kitasatospora sp. MY 5-36 in repeated fed-batch cultures. Bioresour Technol2010; 101: 5523–5527.
29.
NieWYuanXYZhaoJ. Rapidly in situ forming chitosan/ɛ-polylysine hydrogels for adhesive sealants and hemostatic materials. Carbohydr Polym2013; 96: 342–348.
30.
TsutsumiYOndaMNagataS. Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity. PANS2000; 97: 8548–8553.
31.
YoshinoriKKazunoriK. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliver Rev2002; 54: 203–222.
32.
HidenoriOYukioNKazunoriK. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliver Rev2003; 55: 403–419.
33.
KimTSeoHJChoiJS. PAMAM-PEG-PAMAM: Novel triblock copolymer as a biocompatible and efficient gene delivery carrier. Biomacromolecules2004; 5: 2487–2492.
34.
LuoDHaverstickKBelchevaN. Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery. Macromolecules2002; 35: 3456–3462.
35.
LeeFChungJEKurisawaM. An injectable hyaluronic acid–tyramine hydrogel system for protein delivery. J Control Release2009; 134: 186–193.
36.
GuptaDTatorCHShoichetMS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials2006; 27: 2370–2379.
37.
GodinBTouitouE. Transdermal skin delivery: Predictions for humans from in vivo, exvivo and animal models. Adv Drug Deliver Rev2007; 59: 1152–1161.
38.
KongRBhargavaR. Characterization of porcine skin as a model for human skin studies using infrared spectroscopic imaging. Analyst2011; 136: 2359–2366.
39.
BarberoAMFraschHF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro2009; 23: 1–13.
40.
BurkeSAJonesMRLeeBP. Thermal gelation and tissue adhesion of biomimetic hydrogels. Biomed Mater2007; 2: 203–203.
41.
StrehinINahasZAroraK. A versatile pH sensitive chondroitin sulfate–PEG tissue adhesive and hydrogel. Biomaterials2010; 31: 2788–2795.
42.
LihELeeJSParkKM. Rapidly curable chitosan-PEG hydrogels as tissue adhesives for hemostasis and wound healing. Acta Biomater2012; 8: 3261–3269.
43.
FiebrigIHardingSDavisS. Sedimentation analysis of potential interactions between mucins and a putative bioadhesive polymer ultracentrifugation. Prog Colloid Polym Sci1994; 94: 66–73.
44.
PavinattoFJPavinattoACaseliL. Interaction of chitosan with cell membrane models at the air−water interface. Biomacromolecules2007; 8: 1633–1640.
45.
ParkJHChoYWChungH. Synthesis and Characterization of Sugar-Bearing Chitosan Derivatives: Aqueous Solubility and Biodegradability. Biomacromolecules2003; 4: 1087–1091.
JevprasesphantRPennyJJalalR. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm2003; 252: 263–266.
48.
BarkunANMoosaviSMartelM. Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding. Gastrointest Endosc2013; 77: 692–700.
49.
AchneckHESileshiBJamiolkowskiRM. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg2010; 251: 217–228.
50.
GruenRLBrohiKSchreiberM. Haemorrhage control in severely injured patients. The Lancet2012; 380: 1099–1108.
51.
SukKLeeJYKimSH. Synergistic stimulation of fibrinogen gelation by casein kinase II and polycationic compounds. IUBMB Life1997; 42: 487–495.
52.
CoulthardPEspositoMWorthingtonHV. Tissue adhesives for closure of surgical incisions (Review). Cochrane Db Syst Rev2010; 5: Cd004287–Cd004287.
53.
KentALiversedgeNDobbinsB. A prospective, randomized, controlled, double-Masked, multi-center clinical trial of medical adhesives for the closure of laparoscopic incisions. J Minim Invas Gyn2014; 21: 252–258.
54.
MehdizadehMWengHGyawaliD. Injectable citrate-based mussel-inspired tissue bioadhesives with high wet strength for sutureless wound closure. Biomaterials2012; 33: 7972–7983.
55.
ChoELeeJSWebbK. Formulation and characterization of poloxamine-based hydrogels as tissue sealants. Acta Biomater2012; 8: 2223–2232.
56.
SingerAJQuinnJVHollanderJE. The cyanoacrylate topical skin adhesives. Am J Emerg Med2008; 26: 490–496.
